<DOC>
	<DOC>NCT01594255</DOC>
	<brief_summary>This study has been designed in compliance with the ICH-E14 guideline 2005 to evaluate the QT/QTc interval prolongation and proarrhythmic potential for non-antiarrhythmic drugs.</brief_summary>
	<brief_title>CAEB071 Thorough QTc Study in Healthy Volunteers</brief_title>
	<detailed_description />
	<criteria>Healthy male and female subjects age 18 to 50 years (including both) of age included, and in good health as determined by past medical history, physical examination, vital signs, electrocardiogram, and laboratory tests at screening. Smokers and tobacco product users (in the previous 3 months). Use of any prescription drugs, herbal supplements, within four (4) weeks prior to initial dosing, and/or overthecounter (OTC) medication, dietary supplements (vitamins included) within two (2) weeks prior to initial dosing. A marked baseline prolongation of QT/QTcF interval Presence of clinically significant illness Other protocoldefined inclusion/exclusion criteria may apply</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>50 Years</maximum_age>
	<verification_date>May 2012</verification_date>
	<keyword>Healthy volunteer</keyword>
	<keyword>QT intervals</keyword>
	<keyword>ECG</keyword>
	<keyword>QT/QTc interval prolongation and proarrhythmic potential for non-antiarrhythmic drugs</keyword>
</DOC>